What is Evommune 's change in AP?

Evommune (EVMN) reported change in AP of $91.42K in Q1 2026.

How has Evommune 's change in AP changed year-over-year?

Evommune 's change in AP increased by 5.1% year-over-year, from $86.96K to $91.42K.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Evommune EVMN Change in AP

Change in AP at other companies

PfizerPFE

-$117.25M+54.2%

Bausch + LombBLCO

-$94M-309%

BillionToOne, Inc. BLLN

$1.69M-47.6%

Perrigo CompanyPRGO

-$35.9M-599%

Hims & Hers HealthHIMS

$167.64M+1,058%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's change in AP?: Evommune (EVMN) reported change in AP of $91.42K in Q1 2026.
How has Evommune 's change in AP changed year-over-year?: Evommune 's change in AP increased by 5.1% year-over-year, from $86.96K to $91.42K.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.